Literature DB >> 18671479

Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women.

Gregory T Spear1, M Reza Zariffard, Hua Y Chen, Joshua J Anzinger, Kathryn Anastos, John Rusine, John Gatabazi, Audrey L French, Mardge Cohen, Alan L Landay.   

Abstract

Infections and inflammation in the genital tract can influence HIV expression or HIV susceptibility. The goal of this study was to determine if significant relationships exist between cytokines and HIV in genital tract secretions from 57 HIV-seropositive Rwandan women. Genital tract secretions were obtained by cervicovaginal lavage (CVL). Ten different cytokines in CVL were measured by multiplex cytometric bead arrays. HIV RNA in CVL and plasma were measured by quantitative PCR. In univariate analysis, genital tract HIV RNA was significantly associated with plasma HIV RNA and several of the cytokines, while in multivariate analysis, genital tract HIV RNA was significantly associated only with plasma HIV RNA and IL-6. This association of IL-6 with HIV RNA levels suggests that IL-6 is an indicator for conditions that induce HIV expression and that IL-6 may contribute to induction of HIV expression in the genital tract.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671479      PMCID: PMC2792594          DOI: 10.1089/aid.2008.0004

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

1.  A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding.

Authors:  L Al-Harthi; A Kovacs; R W Coombs; P S Reichelderfer; D J Wright; M H Cohen; J Cohn; S Cu-Uvin; H Watts; S Lewis; S Beckner; A Landay
Journal:  AIDS       Date:  2001-08-17       Impact factor: 4.177

2.  Determinants of HIV-1 shedding in the genital tract of women.

Authors:  A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

3.  The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

Authors:  C C Wang; R S McClelland; M Reilly; J Overbaugh; S R Emery; K Mandaliya; B Chohan; J Ndinya-Achola; J Bwayo; J K Kreiss
Journal:  J Infect Dis       Date:  2001-02-28       Impact factor: 5.226

4.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

5.  The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.

Authors:  Yichuan Wang; Kristina Abel; Katherine Lantz; Arthur M Krieg; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.

Authors:  R S Mcclelland; C C Wang; K Mandaliya; J Overbaugh; M T Reiner; D D Panteleeff; L Lavreys; J Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  AIDS       Date:  2001-01-05       Impact factor: 4.177

7.  Monoclonal-antibody-based enzyme-linked immunosorbent assay for Trichomonas vaginalis.

Authors:  P J Lisi; R S Dondero; D Kwiatkoski; M R Spence; M F Rein; J F Alderete
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

8.  Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding.

Authors:  F Zara; R E Nappi; R Brerra; R Migliavacca; R Maserati; A Spinillo
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

9.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.

Authors:  R N Fichorova; M Bajpai; N Chandra; J G Hsiu; M Spangler; V Ratnam; G F Doncel
Journal:  Biol Reprod       Date:  2004-05-05       Impact factor: 4.285

View more
  12 in total

1.  Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.

Authors:  Caroline Mitchell; Jane Hitti; Kathleen Paul; Kathy Agnew; Susan E Cohn; Amneris E Luque; Robert Coombs
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

2.  Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.

Authors:  Catherine A Blish; R Scott McClelland; Barbra A Richardson; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

3.  Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.

Authors:  Tara R Henning; Katherine Butler; Debra Hanson; Gail Sturdevant; Shanon Ellis; Elizabeth M Sweeney; James Mitchell; Frank Deyounks; Christi Phillips; Carol Farshy; Yetunde Fakile; John Papp; W Evan Secor; Harlan Caldwell; Dorothy Patton; Janet M McNicholl; Ellen Kersh
Journal:  J Infect Dis       Date:  2014-04-21       Impact factor: 5.226

4.  High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.

Authors:  Maria L Alcaide; Violeta J Rodriguez; Megan R Brown; Suresh Pallikkuth; Kristopher Arheart; Octavio Martinez; Margaret Roach; Raina N Fichorova; Deborah L Jones; Savita Pahwa; Margaret A Fischl
Journal:  AIDS Res Hum Retroviruses       Date:  2017-01-03       Impact factor: 2.205

5.  Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.

Authors:  Lucy R Mukura; Mimi Ghosh; John V Fahey; Susan Cu-Uvin; Charles R Wira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

Review 6.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.

Authors:  Maria M Bednar; Christa Buckheit Sturdevant; Lauren A Tompkins; Kathryn Twigg Arrildt; Elena Dukhovlinova; Laura P Kincer; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

7.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

8.  HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.

Authors:  Marta E Bull; Jillian Legard; Kenneth Tapia; Bess Sorensen; Susan E Cohn; Rochelle Garcia; Sarah E Holte; Robert W Coombs; Jane E Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

9.  Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.

Authors:  Julie A E Nelson; Kristina De Paris; Catalina Ramirez; Andrew Edmonds; Katie R Mollan; Camden P Bay; Kara Compliment; Betsy C Herold; Kathryn Anastos; Howard Minkoff; Seble Kassaye; Dominika L Seidman; Audrey L French; Elizabeth T Golub; Anandi N Sheth; Christina Ochsenbauer; Ronald Swanstrom; Joseph J Eron; Adaora A Adimora
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

10.  Socio-economic, clinical and biological risk factors for mother - to - child transmission of HIV-1 in Muhima health centre (Rwanda): a prospective cohort study.

Authors:  Maurice Bucagu; Jean de Dieu Bizimana; John Muganda; Claire Perrine Humblet
Journal:  Arch Public Health       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.